SkinBioTherapeutics (GB:SBTX) has released an update.
SkinBioTherapeutics PLC has announced an upcoming presentation for investors on the 11th of October 2024, discussing the company’s advancements in skin health. The event will be hosted on the Investor Meet Company platform, and attendees are encouraged to submit questions in advance or during the live presentation. SkinBioTherapeutics, known for its SkinBiotix® platform, focuses on developing products for cosmetic skincare and food supplements that target the gut-skin axis.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.
